Genscript Biotech Corporation
GNNSF | OTC
$4.50
$0.00 (0.00%)
At close: Oct 28, 2026, 9:30 AM ET
$4.50
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 5:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 959.53M | 594.49M | 560.48M | 625.7M | 490.1M | 390.85M |
Cost of Revenue | 406.32M | 322.36M | 289.85M | 321.62M | 207.58M | 134.95M |
Gross Profit | 553.2M | 272.13M | 270.63M | 304.08M | 282.52M | 255.89M |
Operating Income | 255.25M | 9.28M | 26.19M | -438.11M | -379.29M | -204.55M |
Interest Income | 26.14M | 28.89M | 73.19M | 13.22M | 2.79M | 6.59M |
Pretax Income | -470.53M | -170.8M | 168.89M | -431.69M | -517.36M | -281.9M |
Net Income | -532.83M | 2.96B | -95.48M | -226.85M | -358.71M | -204.95M |
Selling & General & Admin | 226.73M | 209.05M | 191.74M | 352.1M | 303.41M | 197.04M |
Research & Development | 71.23M | 53.79M | 52.7M | 390.1M | 358.4M | 263.4M |
Other Expenses | n/a | n/a | n/a | -138K | n/a | n/a |
Operating Expenses | 297.96M | 262.84M | 244.44M | 742.06M | 661.81M | 460.44M |
Interest Expense | 17.32M | 8.03M | 27.51M | 13.27M | 2.38M | n/a |
Selling & Marketing Expenses | 99.49M | 88.12M | 80.14M | 168.35M | 167.97M | 107.34M |
Cost & Expenses | 704.28M | 585.2M | 534.29M | 1.06B | 869.38M | 595.39M |
Income Tax Expense | 61.87M | 2.98M | 6.01M | -3.72M | 964K | -477K |
Shares Outstanding (Basic) | 2.17B | 2.18B | 2.11B | 2.1B | 2.03B | 1.9B |
Shares Outstanding (Diluted) | 2.19B | 2.18B | 2.11B | 2.1B | 2.03B | 1.9B |
EPS (Basic) | -0.25 | -0.03 | 0.20 | -0.11 | -0.18 | -0.11 |
EPS (Diluted) | -0.25 | -0.03 | 0.20 | -0.11 | -0.18 | -0.11 |
EBITDA | 317.61M | 70.04M | 83.5M | -389.04M | -477.27M | -174.71M |
EBIT | 255.25M | 9.28M | 26.19M | -437.98M | -514.99M | -204.55M |
Depreciation & Amortization | 62.36M | 60.75M | 57.3M | 49.08M | 37.72M | 29.84M |
Add to Watchlist
Select watchlists to add or remove GNNSF